SCHEMBL7738993

SCHEMBL7738993

COc1cccc(-c2nc(-c3ccc(-c4ccccc4)cc3O)oc2NC(=O)c2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.55
KDM4E B2RXH2 4/20 0.52
MAPT P10636 4/20 0.52
POLB P06746 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HSD17B10 Q99714 3/20 0.52
ALDH1A1 P00352 3/20 0.52
HPGD P15428 2/20 0.52
GAA P10253 1/20 0.52
HDAC2 Q92769 1/20 0.51
FLT1 P17948 1/20 0.51
FLT4 P35916 1/20 0.51
TRPV1 Q8NER1 1/20 0.50
LMNA P02545 1/20 0.50
HTT P42858 1/20 0.50
RECQL P46063 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744786 0.91 PLG (0.50) KDRKDM4EMAPTPOLBSMN1; SMN2
SCHEMBL7739015 0.90 KDR (0.68) KDRKDM4EMAPTPOLBSMN1; SMN2
SCHEMBL7746598 0.88 KDR (0.58) KDRHDAC2FLT1FLT4HDAC1
SCHEMBL7738996 0.86 KDR (0.52) KDRKDM4EMAPTPOLBSMN1; SMN2
SCHEMBL7744059 0.85 KDR (0.53) KDRKDM4EMAPTMEN1KMT2A
SCHEMBL7739007 0.84 KDR (0.51) KDRKDM4EMAPTPOLBSMN1; SMN2
SCHEMBL7744787 0.83 KDR (0.47) KDRKDM4EMAPTPOLBSMN1; SMN2
SCHEMBL7985537 0.83 KDR (0.53) KDRKDM4EMAPTSMN1; SMN2MEN1
SCHEMBL7739068 0.82 KDR (0.47) KDRMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL14148491 0.81 KDM4E (0.66) KDRKDM4EMAPTPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed